Your browser doesn't support javascript.
loading
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.
Monticone, Giulia; Huang, Zhi; Csibi, Fred; Leit, Silvana; Ciccone, David; Champhekar, Ameya S; Austin, Jermaine E; Ucar, Deniz A; Hossain, Fokhrul; Ibba, Salome V; Boulares, A Hamid; Carpino, Nicholas; Xu, Keli; Majumder, Samarpan; Osborne, Barbara A; Loh, Christine; Miele, Lucio.
Afiliação
  • Monticone G; Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Huang Z; Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Csibi F; Nimbus Therapeutics, Cambridge, MA, United States.
  • Leit S; Nimbus Therapeutics, Cambridge, MA, United States.
  • Ciccone D; Nimbus Therapeutics, Cambridge, MA, United States.
  • Champhekar AS; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA, United States.
  • Austin JE; Department of Biology, University of Virginia, Charlottesville, VA, United States.
  • Ucar DA; Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Hossain F; Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Ibba SV; Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Boulares AH; Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Carpino N; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY, United States.
  • Xu K; Department of Neurobiology and Anatomical Sciences, University of Mississippi Medical Center, Jackson, MS, United States.
  • Majumder S; Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Osborne BA; Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA, United States.
  • Loh C; Nimbus Therapeutics, Cambridge, MA, United States.
  • Miele L; Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Front Immunol ; 13: 987298, 2022.
Article em En | MEDLINE | ID: mdl-36090975
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma / Neoplasias Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma / Neoplasias Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos